Suppr超能文献

异恶唑并[4,5 - ][1,2,4]三氮杂卓衍生物的新型衍生物及蛋白激酶C潜在抑制剂的合成与抗癌评价

Synthesis and Anticancer Evaluation of Novel Derivatives of Isoxazolo[4,5-][1,2,4]triazepine Derivatives and Potential Inhibitors of Protein Kinase C.

作者信息

Wagner Edwin, Wietrzyk Joanna, Psurski Mateusz, Becan Lilianna, Turlej Eliza

机构信息

Department of Drugs Technology, Wroclaw Medical University, Wroclaw 50-367, Poland.

Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy Sciences, Wroclaw 53-114, Poland.

出版信息

ACS Omega. 2020 Dec 24;6(1):119-134. doi: 10.1021/acsomega.0c03801. eCollection 2021 Jan 12.

Abstract

In the present study, using Thorpe's reaction with Gewald's modification, 4-acetylamino-5-acetyl or 5-benzoyl 3-carboxamide compounds or were obtained. From these compounds, two series of compounds (, , and and , , and ) were obtained with 98% hydrazine. Compounds , , , and were then reacted with the appropriate aldehydes to afford a series of new isoxazole derivatives (, , and ) and the main compounds, and , were isoxazolo[4,5-][1,2,4]triazepine derivatives. The anticarcinogenic activities of selected compounds were tested on six lines of cancer cells, and their activities were compared with the relevant concentrations of the anticarcinogenic drugs cisplatin and doxorubicin in IITD PAN. Several compounds were tested on 60 lines of cancer cells by the NCI (Bethesda, MD, USA). The cyclization of compound into derivative was also carried out. Compound showed extremely high antitumor activity.

摘要

在本研究中,采用经格瓦尔德改进的索普反应,得到了4-乙酰氨基-5-乙酰基或5-苯甲酰基-3-甲酰胺化合物。由这些化合物,用98%的肼得到了两个系列的化合物(……以及……)。然后化合物……与适当的醛反应,得到一系列新的异恶唑衍生物(……),主要化合物……为异恶唑并[4,5 - ][1,2,4]三氮杂䓬衍生物。在六种癌细胞系上测试了所选化合物的抗癌活性,并将它们的活性与印度癌症研究所(IITD PAN)中抗癌药物顺铂和阿霉素的相关浓度进行了比较。美国国立癌症研究所(NCI,马里兰州贝塞斯达)在60种癌细胞系上对几种化合物进行了测试。还进行了化合物……环化为衍生物……的反应。化合物……显示出极高的抗肿瘤活性。 (注:原文中部分化学式或编号未完整给出,翻译时保留原样)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bab/7807470/ae0d3ad892fd/ao0c03801_0002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验